Cerebral peritumoral oedema study: Does a single dynamic MR sequence assessing perfusion and permeability can help to differentiate glioblastoma from metastasis?

European Journal of Radiology

Volumn 81, Issue 3, 2012, Pages 522-527

  Lehmann, Pierre ^a,d,g   Saliou, Guillaume ^c   De Marco, Giovanni ^b   Monet, Pauline ^a   Souraya, Stoquart Elsankari ^e   Bruniau, Alexis ^f   Vallée, Jean Noel ^a   Ducreux, Denis ^c  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ PARIS OUEST NANTERRE LA DÉFENSE   (France)

^c Neuroradiology   (France)

^d CNRS   (France)

^e CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^f Nordpathologie   (France)

^g TIMONE HOSPITAL   (France)

Author keywords

Glioblastoma; Metastasis; MR; Perfusion; Permeability

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN CIRCULATION; BRAIN EDEMA; CEREBRAL PERITUMORAL EDEMA; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; GLIOBLASTOMA; HUMAN; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE; PERFUSION; PERMEABILITY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BIOPSY; BRAIN EDEMA; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLIOBLASTOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84856974658     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2011.01.076     Document Type: Article

References (31)

1. F.G. Davis, B.J. McCarthy, and Berger MS Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Data Base Neuro Oncol 1 1999 205 211
2. T.S. Surawicz, B.J. McCarthy, and V. Kupelian Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994 Neuro Oncol 1 1999 14 25
3. Schiff D Single brain metastasis Curr Treat Options Neurol 3 2001 89 99
4. A. Giese, and M. Westphal Treatment of malignant glioma: a problem beyond the margins of resection J Cancer Res Clin Oncol 127 2001 217 225
5. D.M. Long Capillary ultrastructure in human metastatic brain tumors J Neurosurg 51 1979 53 58
6. S. Cha, J.M. Lupo, and M.H. Chen Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging AJNR Am J Neuroradiol 28 2007 1078 1084
7. D.R. Senger Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines Am J Pathol 149 1996 1 7
8. P. Kleihues, D.N. Louis, and B.W. Scheithauer The WHO classification of tumors of the nervous system J Neuropathol Exp Neurol 61 2002 215 225 [discussion 226-219]
9. E.A. Knopp, S. Cha, and G. Johnson Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging Radiology 211 1999 791 798
10. J.L. Boxerman, K.M. Schmainda, and Weisskoff RM Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not AJNR Am J Neuroradiol 27 2006 859 867
11. P. Meier, and Zierler KL On the theory of the indicator-dilution method for measurement of blood flow and volume J Appl Physiol 6 1954 731 744
12. A.M. Smith, C.B. Grandin, and T. Duprez Whole brain quantitative CBF and CBV measurements using MRI bolus tracking: comparison of methodologies Magn Reson Med 43 2000 559 564
13. A. Preda, P.A. Wielopolski, and T.L. Ten Hagen Dynamic contrast-enhanced MRI using macromolecular contrast media for monitoring the response to isolated limb perfusion in experimental soft-tissue sarcomas Magma 17 2004 296 302
14. M.M. Moasser, L.J. Wilmes, and C.H. Wong Improved tumor vascular function following high-dose epidermal growth factor receptor tyrosine kinase inhibitor therapy J Magn Reson Imaging 26 2007 1618 1625
15. A. Preda, V. Novikov, and M. Moglich MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer J Magn Reson Imaging 20 2004 865 873
16. P. Marzola, P. Farace, and L. Calderan In vivo mapping of fractional plasma volume (fpv) and endothelial transfer coefficient (Kps) in solid tumors using a macromolecular contrast agent: correlation with histology and ultrastructure Int J Cancer 104 2003 462 468
17. K. Turetschek, A. Preda, and V. Novikov Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights J Magn Reson Imaging 20 2004 138 144
18. K. Turetschek, S. Huber, and E. Floyd MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation Radiology 218 2001 562 569
19. M. Law, S. Yang, and J.S. Babb Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade AJNR Am J Neuroradiol 25 2004 746 755
20. M. Law, R.J. Young, and J.S. Babb Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging Radiology 247 2008 490 498
21. J.D. Hazle, E.F. Jackson, and D.F. Schomer Dynamic imaging of intracranial lesions using fast spin-echo imaging: differentiation of brain tumors and treatment effects J Magn Reson Imaging 7 1997 1084 1093
22. H.C. Roberts, T.P. Roberts, and R.C. Brasch Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade AJNR Am J Neuroradiol 21 2000 891 899
23. Y. Cao, Z. Shen, and T.L. Chenevert Estimate of vascular permeability and cerebral blood volume using Gd-DTPA contrast enhancement and dynamic T2*-weighted MRI J Magn Reson Imaging 24 2006 288 296
24. J.M. Provenzale, G.R. Wang, and T. Brenner Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging AJR Am J Roentgenol 178 2002 711 716
25. A. Villringer, B.R. Rosen, and J.W. Belliveau Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects Magn Reson Med 6 1988 164 174
26. F. Dhermain, G. Saliou, and F. Parker Microvascular leakage and contrast enhancement as prognostic factors for recurrence in unfavorable low-grade gliomas J Neurooncol 2009
27. N. Bulakbasi, M. Kocaoglu, and A. Farzaliyev Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors AJNR Am J Neuroradiol 26 2005 2187 2199
28. A. Di Costanzo, T. Scarabino, and F. Trojsi Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy Neuroradiology 48 2006 622 631
29. N. Rollin, J. Guyotat, and N. Streichenberger Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors Neuroradiology 48 2006 150 159
30. I.C. Chiang, Y.T. Kuo, and C.Y. Lu Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings Neuroradiology 46 2004 619 627
31. P. Lehmann, J.N. Vallee, and G. Saliou Dynamic contrast-enhanced T2*-weighted MR imaging: a peritumoral brain oedema study J Neuroradiol 36 2009 88 92